A complete application in a minute
Tailored resume and cover letter, ready to send.
University Health Network in Toronto is seeking a Phase I Student to support the Drug Development Program at Princess Margaret Cancer Centre. This 25-hour-per-week, temporary part-time role runs Monday to Friday, with duties in clinic operations and non-clinical tasks within a fast-paced trials unit.
You will assist with administrative coordination, support nursing and research teams, and gain exposure to early-phase therapeutic studies under the Clinical Research Manager.
The University Health Network, where “above all else the needs of patients come first”, encompasses Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and the Michener Institute of Education. The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of ground-breaking firsts and a purpose of “Transforming lives and communities through excellence in care, discovery and learning”, the University Health Network (UHN), Canada’s largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.
Union: Non-Union
Number of Vacancies: 1
New or Replacement Position: New
Site: Princess Margaret Cancer Centre
Department: Drug Development Program – Phase 1
Reports to: Clinical Research Manager
Salary Range:$17.95 - $21.38 per hour
Hours: 25 Hours Per Week
Shifts: Monday – Friday
Status: Temporary Part-Time (Contract until September 30th, 2027)
Closing Date: December 3, 2026
The Drug Development Program at Princess Margaret Hospital is the largest drug development program in Canada and the only centre outside of the United States to have a contract with the National Institutes of Health (NIH) for Early Phase Therapeutic studies. The Drug Development Program includes a Phase I program, focusing on studies of innovative drugs and immunotherapy, with a strong emphasis on pharmacokinetics and correlative studies. It involves a collaborative and multidisciplinary approach and is strategically designed to ensure the rapid completion of high-quality studies.
The DDP Phase I Student will support the day-to-day operations of the Phase I Clinical Trials Unit, assisting with clinic flow, administrative coordination, and other non-clinical activities. The role involves working collaboratively with a multidisciplinary team in a fast-paced clinical research environment to support efficient clinic operations.
In addition to working alongside some of the most talented and inspiring healthcare professionals in the world, UHN offers a wide range of benefits, programs and perks. It is the comprehensiveness of these offerings that makes it a differentiating factor, allowing you to find value where it matters most to you, now and throughout your career at UHN.
Current UHN employees must have successfully completed their probationary period, have a good employee record along with satisfactory attendance in accordance with UHN's attendance management program, to be eligible for consideration.
Please be advised that a Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.
UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.
We thank all applicants for their interest, however, only those selected for further consideration will be contacted.